REQUEST A DEMO
Total
USD $0.00
Search more companies

Cosar Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Cosar Pharmaceutical Company Public Joint Stock Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Cosar Pharmaceutical Co. is an Iranian producer of anti-biotics. The company commenced operations in 1974 under its previous name Chemico Pharmaceutical. It started with the production of oral antibiotics of the penicillin family and later on, it expanded to include in its portfolio amoxicillin, ampicillin and cloxacillin. In 2015 the company launched a new production line for general drugs in the forms of capsules, tablets, sachets and suspensions.

Headquarters
17Km Old Way Karaj, Darougar St, P.O. Box :1388154311
Tehran; Tehran;

Contact Details: Purchase the Cosar Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.cosarpharm.com

Basic Information
Total Employees:
Purchase the Cosar Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Cosar Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Cosar Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1974
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
18%
Purchase this report to view the information.
11%
Purchase this report to view the information.
8%
Purchase this report to view the information.
7%
Subsidiaries
Amin Pharmaceutical Company Public Joint Stock
Emroz Single Information Processing Company
Helpak Private Joint Stock Company
Company Performance
Financial values in the chart are available after Cosar Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
35.48%
Total operating revenue
35.48%
Operating profit (EBIT)
4.14%
Net Profit (Loss) for the Period
-40.86%
Total assets
71.04%
Total equity
35.32%
Operating Profit Margin (ROS)
-7.35%
Net Profit Margin
-11.8%
Return on Equity (ROE)
-9.65%
Debt to Equity Ratio
26.07%
Quick Ratio
0.01%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?